// App-Quantinova.ai

BSH2020‐PO‐185 : Group O D negative blood – promoting the appropriate use of an essential but limited resource

Researchers

Presenter

  • S. Allard

Principal Investigators

  • D. Foukaneli

  • M. Bend

  • L. Estcourt

  • L. Sherliker

Medical Centers

  • Clinical, Medical, NHS Blood and Transplant

  • Clinical, Medical, NHS Blood and Transplant

  • Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge

  • Blood Stocks Management Scheme, NHS Blood and Transplant, Sheffield

  • Clinical, Medical

  • Patient Blood Management, NHS Blood and Transplant, Oxford, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Sickle cell anemia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A